Isofoton says it will table a bid at a meeting of Q-Cells’ creditors’ committee tomorrow, offering it a late alternative to an agreement Hanwha has already signed with the German company’s administrators. Any deal is subject to the committee's approval.
The amount of the Isofoton bid has not been disclosed. It will be made in conjunction with an unidentified US investment fund.
Isofoton
